Anika Therapeutics, Inc. (ANIK)

NASDAQ: ANIK · Real-Time Price · USD

20.99

0.00 (-0.02%)

At close: Sep 11, 2026, 4:00 PM EDT

20.86

-0.13 (-0.60%)

After-hours: Sep 11, 2026, 7:30 PM EDT

Anika Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	38.41	57.48	55.63	68.74	86.33	94.39
Cash & Short-Term Investments	38.41	57.48	55.63	68.74	86.33	94.39
Cash Growth	-27.75%	3.33%	-19.07%	-20.37%	-8.54%	-4.00%
Receivables	29.06	23.69	23.59	26.36	34.63	29.84
Inventory	28.57	18.79	23.81	24.43	39.77	36.01
Prepaid Expenses	3.15	3.4	5.49	7.48	8.83	8.29
Other Current Assets	-	-	5.13	36.31	-	-
Total Current Assets	99.19	103.36	113.65	163.31	169.55	168.53
Property, Plant & Equipment	65.05	66.26	64.68	65	78.98	68.56
Goodwill	7.83	8.05	7.13	7.57	7.34	7.78
Other Intangible Assets	1.65	1.65	2.49	2.58	74.6	82.38
Long-Term Deferred Tax Assets	1.02	1.28	1.18	1.49	1.45	-
Other Long-Term Assets	3.02	4.03	7.68	30.69	17.22	20.29
Total Assets	183.47	190.27	202.74	270.63	349.13	347.54

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	6.24	6.04	5.62	6.19	9.07	7.63
Accrued Expenses	13.53	13.82	11.59	11	15.96	16.13
Current Portion of Leases	1.94	2.05	1.92	1.83	2.07	1.71
Current Income Taxes Payable	-	-	0.06	1.24	0.81	-
Current Unearned Revenue	0.12	-	-	-	-	-
Other Current Liabilities	0.33	-	4.12	10.8	-	4.32
Total Current Liabilities	22.15	21.91	23.31	31.06	27.91	29.8
Long-Term Leases	23.32	24.2	24.01	25.92	28.82	19.24
Long-Term Deferred Tax Liabilities	-	-	-	-	6.44	10.16
Other Long-Term Liabilities	0.73	0.7	1.43	1.39	0.4	1.26
Total Liabilities	46.19	46.81	48.75	58.37	63.57	60.45

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.13	0.14	0.14	0.15	0.15	0.14
Additional Paid-In Capital	83.44	87.5	88.96	90.01	81.14	67.08
Retained Earnings	59.04	60.79	71.67	128.05	210.72	225.58
Comprehensive Income & Other	-5.33	-4.96	-6.78	-5.94	-6.44	-5.72
Shareholders' Equity	137.28	143.47	153.99	212.27	285.56	287.09
Total Liabilities & Equity	183.47	190.27	202.74	270.63	349.13	347.54

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	25.25	26.25	25.93	27.74	30.89	20.95
Net Cash (Debt)	13.16	31.23	29.7	41	55.44	73.43
Net Cash Growth	-53.29%	5.17%	-27.57%	-26.05%	-24.51%	-3.19%
Net Cash Per Share	0.95	2.18	2.02	2.80	3.81	5.02
Filing Date Shares Outstanding	13.38	13.4	14.18	14.66	14.63	14.47
Total Common Shares Outstanding	13.38	13.89	14.42	14.66	14.63	14.44
Working Capital	77.04	81.45	90.35	132.25	141.63	138.73
Book Value Per Share	10.26	10.33	10.68	14.48	19.53	19.88
Tangible Book Value	127.81	133.76	144.37	202.12	203.63	196.92
Tangible Book Value Per Share	9.55	9.63	10.01	13.79	13.92	13.64
Machinery	55.17	51.2	42.9	44.39	54.53	51.19
Construction In Progress	2.13	3.73	6.04	2.39	5.02	1.38
Leasehold Improvements	37.02	36.82	36.34	34.65	34.92	34.61

SEC Filings: 10-K · 10-Q